0000921895-23-000097.txt : 20230111
0000921895-23-000097.hdr.sgml : 20230111
20230111171140
ACCESSION NUMBER: 0000921895-23-000097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230109
FILED AS OF DATE: 20230111
DATE AS OF CHANGE: 20230111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Radoff Bradley Louis
CENTRAL INDEX KEY: 0001380585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38861
FILM NUMBER: 23524205
MAIL ADDRESS:
STREET 1: 2727 KIRBY DRIVE
STREET 2: UNIT 29L
CITY: HOUSTON
STATE: TX
ZIP: 77098
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Radoff Family Foundation
CENTRAL INDEX KEY: 0001496916
STATE OF INCORPORATION: TX
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38861
FILM NUMBER: 23524204
BUSINESS ADDRESS:
STREET 1: 2727 KIRBY DRIVE
STREET 2: UNIT 29L
CITY: HOUSTON
STATE: TX
ZIP: 77098
BUSINESS PHONE: 713.877.0089
MAIL ADDRESS:
STREET 1: 2727 KIRBY DRIVE
STREET 2: UNIT 29L
CITY: HOUSTON
STATE: TX
ZIP: 77098
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardion Health Sciences, Inc.
CENTRAL INDEX KEY: 0001642375
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474428421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2925 RICHMOND AVENUE
STREET 2: SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
BUSINESS PHONE: (800) 873-5141
MAIL ADDRESS:
STREET 1: 2925 RICHMOND AVENUE
STREET 2: SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
FORMER COMPANY:
FORMER CONFORMED NAME: Guardion Health Sciences, LLC
DATE OF NAME CHANGE: 20150513
4
1
form409076ghsi_01112023.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-09
0
0001642375
Guardion Health Sciences, Inc.
GHSI
0001380585
Radoff Bradley Louis
2727 KIRBY DRIVE
UNIT 29L
HOUSTON
TX
77098
0
0
1
0
0001496916
Radoff Family Foundation
2727 KIRBY DRIVE
UNIT 29L
HOUSTON
TX
77098
0
0
0
1
See Footnote 1
Common Stock
2023-01-09
4
P
0
63983
6.7762
A
165162
D
Common Stock
2023-01-09
4
P
0
20838
7.1948
A
186000
D
Common Stock
2023-01-10
4
P
0
18630
7.3112
A
204630
D
Common Stock
2023-01-10
4
P
0
13270
7.9989
A
217900
D
Common Stock
25100
I
By The Radoff Family Foundation
This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.7762 to $7.0417 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.05 to $7.48 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.75 to $7.70 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.97 to $8.00 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.
/s/ Bradley L. Radoff
2023-01-11
The Radoff Family Foundation, By: /s/ Bradley L. Radoff, Director
2023-01-11